Oarsman Capital’s Raymond James Financial RJF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Buy
12,117
+303
+3% +$46K 0.2% 74
2026
Q1
$1.71M Buy
11,814
+99
+0.8% +$15.7K 0.21% 77
2025
Q4
$1.88M Buy
11,715
+488
+4% +$78.8K 0.24% 71
2025
Q3
$1.94M Buy
11,227
+84
+0.8% +$13.9K 0.27% 66
2025
Q2
$1.71M Buy
11,143
+277
+3% +$39.7K 0.27% 75
2025
Q1
$1.51M Buy
10,866
+212
+2% +$32.9K 0.27% 80
2024
Q4
$1.65M Buy
10,654
+323
+3% +$48.8K 0.29% 69
2024
Q3
$1.27M Buy
10,331
+225
+2% +$26.3K 0.23% 82
2024
Q2
$1.25M Buy
10,106
+320
+3% +$39.5K 0.27% 77
2024
Q1
$1.26M Sell
9,786
-974
-9% -$113K 0.3% 77
2023
Q4
$1.2M Buy
10,760
+99
+0.9% +$10.2K 0.32% 75
2023
Q3
$1.07M Buy
10,661
+391
+4% +$41.4K 0.45% 60
2023
Q2
$1.07M Buy
10,270
+2,588
+34% +$240K 0.47% 59
2023
Q1
$717K Buy
7,682
+3,076
+67% +$326K 0.33% 76
2022
Q4
$492K Buy
+4,606
New +$517K 0.25% 89

Other funds holding RJF

Oarsman Capital's RJF Position: Q2 2026 in Review

Oarsman Capital increased its Raymond James Financial (RJF) stake by 2.6% in Q2 2026, buying an estimated $46K and bringing the position to 12,117 shares worth $1.84M. The position accounts for 0.2% of the portfolio, ranked #74.

Oarsman Capital first reported a position in RJF in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.94M in Q3 2025. 897 funds tracked by Wall St. Rank hold RJF as of Q2 2026.

  • Oarsman Capital held 12,117 shares of Raymond James Financial worth $1.84M as of Q2 2026.
  • Oarsman Capital bought 303 Raymond James Financial shares in Q2 2026, an estimated $46K.
  • Raymond James Financial made up 0.2% of Oarsman Capital's portfolio in Q2 2026, its #74 holding.
  • Oarsman Capital first reported a position in Raymond James Financial in Q4 2022 and has held it in 15 quarters since.
  • Oarsman Capital's Raymond James Financial position peaked at $1.94M in Q3 2025.
  • 897 funds tracked by Wall St. Rank held Raymond James Financial as of Q2 2026.

Based on Oarsman Capital's 13F filing for Q2 2026, filed 7 Aug 2026.